Clinical Trials Logo

Filter by:
NCT ID: NCT00628043 Completed - Anemia Clinical Trials

Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients

Start date: May 2008
Phase: Phase 3
Study type: Interventional

This is a study to investigate the clinical efficacy and safety of epoetin beta 36,000 IU compared with placebo when administrated subcutaneously (s.c.) once-weekly for 12 weeks to anemic patients with lung cancer or gynecologic cancer undergoing chemotherapy.

NCT ID: NCT00627731 Completed - Asthma Clinical Trials

Oral Glucocorticosteroid in the Treatment of Severe Asthma Exacerbation in Hospitalized Patients

Start date: June 2007
Phase: Phase 4
Study type: Interventional

A comparison of oral prednisolone administration with intravenous methylprednisolone infusion in the treatment of acute asthma exacerbation in hospitalized patients. Oral glucocorticosteroids administration may be effective as intravenous high-dose methylprednisolone infusion.

NCT ID: NCT00626912 Completed - Clinical trials for Subarachnoid Hemorrhage

PRET: Patients Prone to Recurrence After Endovascular Treatment

PRET
Start date: June 2007
Phase: Phase 4
Study type: Interventional

The PRET study aims at comparing two types of coils used in the endovascular treatment of intracranial aneurysms. The first type made of platinum has been used for more than 15 years. The other, referred to as hydrocoil, containing in addition to platinum a polymer layer that expands when in contact with blood, has been in use since 2002. The hypothesis of the PRET study is that the newer hydrocoil will be more effective and yet as safe as the older platinum coil.

NCT ID: NCT00622830 Completed - Atherosclerosis Clinical Trials

Phase I Study of SB-480848(Darapladib) -Repeat Dose Study in Healthy Japanese Male Subjects-

Start date: January 2008
Phase: Phase 1
Study type: Interventional

This study is being conducted to provide safety, tolerability, PK and PD data in repeat dosing that will allow further studies with darapladib in Japanese patients

NCT ID: NCT00622622 Completed - Pancreatic Cancer Clinical Trials

Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer

Start date: November 2006
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability and immune response of different doses of VEGFR2-169 emulsified with Montanide ISA 51 in combination with gemcitabine and to determine the recommended phase II dose.

NCT ID: NCT00622258 Completed - Clinical trials for Non-Hodgkin's Lymphoma

A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Start date: March 2008
Phase: Phase 1
Study type: Interventional

This study assesses the tolerability, safety, efficacy and pharmacokinetics of everolimus in Japanese patients. Everolimus is administered orally everyday to adult patients with relapsed or refractory non-Hodgkin's lymphoma who have progressed despite standard therapy or for whom standard systemic therapy dose not exist.

NCT ID: NCT00621868 Completed - Diabetes Mellitus Clinical Trials

A Study of ASP1941 in Participants With Type 2 Diabetes Mellitus

Start date: March 26, 2008
Phase: Phase 2
Study type: Interventional

The objective of this study is to evaluate the efficacy, safety and pharmacokinetics of ASP1941 in male and female patients with type 2 diabetes mellitus

NCT ID: NCT00621296 Completed - Hepatitis C Clinical Trials

Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C

Start date: January 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy and safety after administration of MP-424 to patients with chronic hepatitis C.

NCT ID: NCT00620555 Completed - Epilepsies, Partial Clinical Trials

A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

Start date: May 2008
Phase: Phase 3
Study type: Interventional

Examine the safety and efficacy of gabapentin as adjunctive therapy in Japanese pediatric patients with partial seizures

NCT ID: NCT00619294 Completed - Coronary Vasospasm Clinical Trials

Endothelial Dysfunction and Coronary Artery Spasm

Start date: August 2006
Phase: N/A
Study type: Observational

Non-obstructive coronary artery disease (NOCAD) frequently accounts for myocardial ischemia in women. Endothelial dysfunction is a pathogenic factor in coronary spastic angina (CSA). CSA is an important cause of NOCAD diagnosed invasively by coronary angiography (CAG). Digital reactive hyperemia peripheral arterial tonometry (RH-PAT) provides noninvasive evaluation of endothelial dysfunction. The investigators hypothesized that the fingertip RH-PAT could predict the presence of CSA in women.